Endomines has been approved for secondary listing on NASDAQ OMX Helsinki and publishes prospectus

NASDAQ OMX Helsinki has approved Endomines AB (publ) (“Endomines”) to be listed on the main list. Endomines filed the application on 2 May 2013 and the first day of trading in Endomines’ share on NASDAQ OMX Helsinki is planned to be on 14 May 2013. Endomines shall maintain its primary listing on NASDAQ OMX Stockholm where the share will keep the same ticker as before, i.e. “ENDO”. On NASDAQ OMX Helsinki the short name will be “ENDOM”. The share will keep the same ISIN as before, i.e. SE0001803131.

No new shares are issued in connection with the secondary listing. Those shareholders, who have purchased their shares in Sweden and want to trade these in Finland at NASDAQ OMX Helsinki, shall transfer their shares to custody in the Finnish book-entry system. Shareholders are referred to their Finnish account operator for help in this matter.

More information can be found in the prospectus that has been prepared in connection with the secondary listing and has been approved by the Swedish FSA (Finansinspektionen). The prospectus will be passported to Finland, which is a condition for the approval of the secondary listing by NASDAQ OMX Helsinki. The prospectus is available on Endomines’ website, www.endomines.com, and on Pareto Öhman’s website, www.paretosec.com.

”A listing of our shares in Helsinki will make it easier for Finnish investors to invest in our shares. I believe Endomines is an interesting investment for many Finns, since we have shown a steady progress in our gold production since the mining commenced. Also, we have a proven track record of meeting our goals and delivering according to plan”, Markus Ekberg, CEO of Endomines comments.

Pareto Öhman AB is acting as financial advisor and Cederquist as legal advisor to Endomines in connection with the listing.